Analysts Set Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Target Price at $12.75
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) has earned a consensus recommendation of “Hold” from the seven brokerages that are currently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among […]
More Stories
10 Fun Things To Do Online When Bored
It’s a lot easier to find ourselves in a state of boredom than it should be. After all, you’re very...
Voya Investment Management LLC Sells 514 Shares of OSI Systems, Inc. (NASDAQ:OSIS)
Voya Investment Management LLC decreased its holdings in shares of OSI Systems, Inc. (NASDAQ:OSIS – Free Report) by 9.7% in...
Trump Announces ‘Full And Comprehensive’ Trade Agreement With UK
By Chris Summers President Donald Trump said on Thursday that a “full and comprehensive” trade deal has been agreed with...
Police Arrest Pro-Palestinian Protesters Occupying Columbia University Library
By Rachel Acenas Multiple people were arrested on May 7 during pro-Palestinian demonstrations at Columbia University in New York. Dozens...
Tudor Investment Corp ET AL Sells 14,940 Shares of Independent Bank Corp. (NASDAQ:INDB)
Tudor Investment Corp ET AL lowered its stake in shares of Independent Bank Corp. (NASDAQ:INDB – Free Report) by 54.9%...
The Manufacturers Life Insurance Company Buys 3,981 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)
The Manufacturers Life Insurance Company boosted its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 12.7%...